BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 2555918)

  • 1. Failure of somatostatin analogue SMS 201-995 to control Cushing's syndrome due to ectopic release of ACTH from a bronchial carcinoid.
    Burrell L; Gray CE; Thomson JA
    Scott Med J; 1989 Oct; 34(5):533-4. PubMed ID: 2555918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cushing's syndrome induced by the ectopic production of ACTH by a bronchial carcinoid.
    Jones JE; Shane SR; Gilbert E; Flink EB
    J Clin Endocrinol Metab; 1969 Jan; 29(1):1-5. PubMed ID: 4302912
    [No Abstract]   [Full Text] [Related]  

  • 3. Lung carcinoid with Cushing's syndrome: control of serum ACTH and cortisol levels using SMS 201-995 (sandostatin).
    Hearn PR; Reynolds CL; Johansen K; Woodhouse NJ
    Clin Endocrinol (Oxf); 1988 Feb; 28(2):181-5. PubMed ID: 2844445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bronchial carcinoid associated with Cushing's syndrome.
    Oliaro A; Filosso PL; Casadio C; Ruffini E; Mazza E; Molinatti M; Cianci R; Porrello C; Rastelli M; Oliveri F
    J Cardiovasc Surg (Torino); 1995 Oct; 36(5):511-4. PubMed ID: 8522574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of somatostatin analogue to control Cushing's syndrome in two cases of ACTH-producing carcinoid tumours.
    Cheung NW; Boyages SC
    Clin Endocrinol (Oxf); 1992 Apr; 36(4):361-7. PubMed ID: 1424169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tinea incognito complicating Cushing's syndrome secondary to a bronchial carcinoid tumour.
    Shaheen B; Irvine F; Freel M; O'Mahony O; Shankland GS; Matthews D; Wainwright NJ
    Eur J Dermatol; 2011; 21(5):805-6. PubMed ID: 21742596
    [No Abstract]   [Full Text] [Related]  

  • 7. Cushing's syndrome and bronchial carcinoid tumour.
    Ward PS; Mott MG; Smith J; Hartog M
    Arch Dis Child; 1984 Apr; 59(4):375-7. PubMed ID: 6326695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Cushing's syndrome with the long-acting somatostatin analogue SMS 201-995 (sandostatin).
    Invitti C; de Martin M; Brunani A; Piolini M; Cavagnini F
    Clin Endocrinol (Oxf); 1990 Mar; 32(3):275-81. PubMed ID: 2160871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bronchopulmonary carcinoid presenting as dexamethasone suppressible Cushing's syndrome.
    Sofka S; Jackson T
    W V Med J; 2013; 109(1):26-8. PubMed ID: 23413545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Octreotide and ectopic Cushing's syndrome--a commentary.
    James RA
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):419-20. PubMed ID: 9876337
    [No Abstract]   [Full Text] [Related]  

  • 11. Bronchial Carcinoid Tumour as a Rare Cause of Cushing’s Syndrome in Children: A Case Report and Review of Literature.
    Saxena R; Pathak M; Shukla R; Sinha A; Elhence P; Bharti JN; Khera P
    J Clin Res Pediatr Endocrinol; 2020 Nov; 12(4):340-346. PubMed ID: 31898446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Octreotide and ketoconazole for persistent ectopic ACTH Cushing's disease due to mediastinal carcinoid.
    Parthiban A; Sundaram DS; Reddy DJ; Girinath MR; Prabhakaran R; Chidambaranathan N
    J Assoc Physicians India; 1995 Feb; 43(2):140. PubMed ID: 9282686
    [No Abstract]   [Full Text] [Related]  

  • 13. [Bronchial carcinoid tumor and Cushing's syndrome. Apropos of 3 cases].
    Merlier M; Luton JP; Bertagna X; Cerrina J; Rojas-Miranda A
    Ann Chir; 1987; 41(2):95-8. PubMed ID: 3039903
    [No Abstract]   [Full Text] [Related]  

  • 14. [Successful conservative treatment of bronchial carcinoid with Cushing's syndrome due to ectopic ACTH production].
    Herrlinger JD; Euler HH; Kleine L; Kirmse L; Müller-Hermelink HK; Löffler H
    Dtsch Med Wochenschr; 1983 Aug; 108(31-32):1200-4. PubMed ID: 6872874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ectopic ACTH- or CRH-secreting tumors in Cushing's syndrome].
    Saeger W; Reincke M; Scholz GH; Lüdecke DK
    Zentralbl Pathol; 1993 Jun; 139(2):157-63. PubMed ID: 8396419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of radioguided surgery with [111In]-pentetreotide in the management of an ACTH-secreting bronchial carcinoid causing ectopic Cushing's syndrome.
    Grossrubatscher E; Vignati F; Dalino P; Possa M; Belloni PA; Vanzulli A; Bramerio M; Marocchi A; Rossetti O; Zurleni F; Loli P
    J Endocrinol Invest; 2005 Jan; 28(1):72-8. PubMed ID: 15816375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cushing's syndrome associated with a chemodectoma and a carcinoid tumour.
    Tremble JM; Buxton-Thomas M; Hopkins D; Kane P; Bailey D; Harris PE
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):789-93. PubMed ID: 10848885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenocorticotropin-secreting carcinoid tumour identified and treated 12 years after presentation with Cushing's syndrome.
    Vaidya B; Richardson D; Hilton CJ; Kendall-Taylor P
    Postgrad Med J; 1997 Nov; 73(865):737-9. PubMed ID: 9519192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cushing's syndrome secondary to bronchial carcinoid tumor: contribution of gammagraphy with 111In-DTPA octreotide in the localization diagnosis].
    Peña González E; Lampreave Márquez JL; León Atance P; Moreno Esteban B; Bittini Copano A; Folqué Gómez E
    An Med Interna; 1999 Nov; 16(11):577-9. PubMed ID: 10637999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment with ketoconazole of Cushing's syndrome due to ectopic secretion of ACTH].
    Pérez Gracia A; Ramírez L; Herrero V; Espinosa J
    Rev Clin Esp; 1992 Dec; 191(9):507-8. PubMed ID: 1488549
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.